Author

Lingge Bi

Observed names: L. Bi, Linda Bi, Linda W Bi

Institutions: Brigham and Women's Hospital, Harvard University

Observed institutions: Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

OpenAlex ID: A5113800033

Immune Profiling of Meningiomas

2023 · Justin Z. Wang, Farshad Nassiri, et al. · Advances in experimental medicine and biology · 7

TIP-11. MOMENTUM-1: a multicenter, randomized, open-label, phase 2 study of [177Lu]Lu-DOTA-TATE in adults with progressive grade 1-3 meningioma (RTOG 3523)

2025 · Sylvia C Kurz, Nusrat Rabbee, et al. · Neuro-Oncology · 2

A Prognostic Molecular Scoring System to Guide the Adjuvant Management of Patients With Gross Totally Resected Atypical Meningioma

2015 · A.A. Aizer, M. Abedalthagafi, et al. · International Journal of Radiation Oncology*Biology*Physics · 1

The Impact of TERT Promoter Mutation on Meningioma Outcome is Context-Dependent: Implications for Clinical Grading and Risk Stratification

2025 · Karenna J. Groff, Ruchit V. Patel, et al. · SSRN Electronic Journal

Works count: 4

Citation count: 10

H-index: 2

I10-index: